MARKET

FBIO

FBIO

Fortress Biotech Inc
NASDAQ
1.650
-0.090
-5.17%
Opening 15:46 05/14 EDT
OPEN
1.760
PREV CLOSE
1.740
HIGH
1.760
LOW
1.650
VOLUME
94.69K
TURNOVER
--
52 WEEK HIGH
2.890
52 WEEK LOW
1.325
MARKET CAP
48.79M
P/E (TTM)
-0.6136
1D
5D
1M
3M
1Y
5Y
1D
Checkpoint Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters · 22h ago
*Correct: Checkpoint Therapeutics 1Q EPS 19c >CKPT
Dow Jones · 23h ago
*Correct: Checkpoint Therapeutics 1Q Loss/Shr 19c >CKPT
Dow Jones · 23h ago
*Correct: Checkpoint Therapeutics 1Q Loss $11.2M >CKPT
Dow Jones · 23h ago
Press Release: Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
Dow Jones · 23h ago
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
Barchart · 1d ago
Weekly Report: what happened at FBIO last week (0505-0509)?
Weekly Report · 2d ago
Fortress Biotech management to meet virtually with Roth MKM
TipRanks · 6d ago
More
About FBIO
More
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.
Recently
Symbol
Price
%Change

Webull offers Fortress Biotech Inc stock information, including NASDAQ: FBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBIO stock methods without spending real money on the virtual paper trading platform.